Having worked in the robot-assisted surgery field, I can tell you that Mako (Abovitz's previous "success") was similarly hyped and was acquired for an enormous sum despite the facts that (1) surgeons hate using it and (2) patient outcomes are no better [https://www.ncbi.nlm.nih.gov/pubmed/24574012]